Phage, yeast, and mammalian display are responsible for the creation of an astonishing array of biologics against a broad range of targets. The 26th Annual Display of Biologics conference at the PEGS Boston Summit is where the leaders in protein engineering come together to share the latest approaches and platforms, using phage and yeast display for the generation of therapeutic molecules against a wide range of indications. This conference is the cornerstone of PEGS Boston and is the premier event of the year for meeting face-to-face with leaders in the industry to hear about the newest developments that drive innovation and progress in biologics.
Scientific Advisory Board
Andrew R.M. Bradbury, MB BS, PhD, CSO, Specifica, Inc.
Jennifer R. Cochran, PhD, Shriram Chair of Bioengineering; Professor of Bioengineering, and (by courtesy)
Chemical Engineering, Stanford University
E. Sally Ward, PhD, Director, Translational Immunology; Professor, Molecular Immunology, Centre for Cancer
Immunology, University of Southampton
Gregory A. Weiss, PhD, Professor, Chemistry, Pharmaceutical Sciences, Molecular Biology & Biochemistry,
University of California, Irvine
K. Dane Wittrup, PhD, J.R. Mares Professor, Chemical Engineering & Bioengineering, Massachusetts Institute
of Technology